DEGRADATION OF MELANOTROPIN INHIBITING FACTOR BY BRAINHUI KS; CHENG KP; WONG KH et al.1980; J. NEUROCHEM.; GBR; DA. 1980; VOL. 35; NO 2; PP. 471-478; BIBL. 30 REF.Article

SYNTHESIS OF ANALOGUES OF THE MELANOCYTE-STIMULATING HORMONE RELEASE-INHIBITING FACTOR CONTAINING 2-OXOIMIDAZOLIDINE-1-CARBOXYLIC ACIDKASAFIREK E; KREJCI I; FELT V et al.1980; COLLECT. CZECH. CHEM. COMMUN.; ISSN 0010-0765; CSK; DA. 1980; VOL. 45; NO 1; PP. 294-297; BIBL. 18 REF.Article

Improvement in major depression after low subcutaneous doses of MIF-1EHRENSING, R. H; KASTIN, A. J; WURZLOW, G. F et al.Journal of affective disorders. 1994, Vol 31, Num 4, pp 227-233, issn 0165-0327Article

Saturable transport of peptides across the blood-brain barrierBANKS, W. A; KASTIN, A. J.Life sciences (1973). 1987, Vol 41, Num 11, pp 1319-1338, issn 0024-3205Article

ELECTRON IMPACT AND METHANE, ISOBUTANE AND AMMONIA CHEMICAL IONIZATION MASS SPECTRA OF PEPTIDE AMIDES RELATED TO MELANOSTATIN (PRO-LEU-GLY-NH₂)BJORKMAN S.1982; BIOMEDICAL MASS SPECTROMETRY; ISSN 0306-042X; GBR; DA. 1982; VOL. 9; NO 8; PP. 315-322; BIBL. 25 REF.Article

Rapid clinical effectiveness of MIF-I in the treatment of major depressive illnessVAN DER VELDE, C. D.Peptides (New York, NY. 1980). 1983, Vol 4, Num 3, pp 297-300, issn 0196-9781Article

THEORETICAL STUDIES ON PRO-LEU-GLY-NH₂ CONFORMATION.SUNGZONG KANG; WALTER R.1976; PROC. NATION. ACAD. SCI. U.S.A.; U.S.A.; DA. 1976; VOL. 73; NO 4; PP. 1203-1206; BIBL. 17 REF.Article

CONFORMATIONAL ENERGY ANALYSIS OF MELANOSTATINZIMMERMAN SS; BAUM R; SCHERAGA HA et al.1982; INT. J. PEPT. PROTEIN. RES.; ISSN 0367-8377; DNK; DA. 1982; VOL. 19; NO 2; PP. 143-152; BIBL. 33 REF.Article

LASER RAMAN STUDIES ON THE CONFORMATION OF PRO-LEU-GLY-NH₂HSEU TH; CHANG H.1980; BIOCHIM. BIOPHYS. ACTA; NLD; DA. 1980; VOL. 624; NO 2; PP. 340-345; BIBL. 16 REF.Article

MIF-1 and Tyr-MIF-1 augment GABA-stimulated benzodiazepine receptor bindingMILLER, L. G; KASTIN, A. J.Peptides (New York, NY. 1980). 1987, Vol 8, Num 5, pp 751-755, issn 0196-9781Article

Dopamine receptor antagonists block the effecxt of TYR-MIF-1 (TYR-PRO-LEU-GLY-NH₂) on the opioate form of footshock-induced analgesiaKROWICKI, Z. K.Neuropeptides (Edinburgh). 1991, Vol 19, Num 4, pp 281-285, issn 0143-4179Article

An NPY-like peptide may function as MSH-release inhibiting factor in Xenopus laevisLIDY VERBURG-VAN KEMENADE, B. M; JENKS, B. G; DANGER, J.-M et al.Peptides (New York, NY. 1980). 1987, Vol 8, Num 1, pp 61-67, issn 0196-9781Article

An analog of MIF, alaptide: effect of serum prolactin, dopamine receptors and growth of rat adenohypophysisNEDVIDKOVA, J; KASAFIREK, E; NEDVIDEK, J et al.Endocrine research. 1994, Vol 20, Num 1, pp 39-46, issn 0743-5800Article

Inhibition by MIF-I of α-MSH induced increase of intraocular pressure and miosis in rabbitsMCCULLEN, R. K; PEIPFFER, R. L; JENNES, L et al.Neuropeptides (Edinburgh). 1988, Vol 12, Num 4, pp 213-217, issn 0143-4179Article

Effects of Pro-Leu-Gly-NH₂ and cyclo (Leu-Gly) on the binding of ³H-quinuclidinyl benzilate to striatal cholinergic muscarinic receptorsDAS, S; MATWYSHYN, G. A; BHARGAVA, H. N et al.Peptides (New York, NY. 1980). 1986, Vol 7, Num 1, pp 21-25, issn 0196-9781Article

17β estradiol-induced increase in brain dopamine D-2 receptor: antagonism by MIF-1RAJAKUMAR, G; CHIU, P; CHIU, S et al.Peptides (New York, NY. 1980). 1987, Vol 8, Num 6, pp 997-1002, issn 0196-9781Article

Down-regulation of haloperidol-induced striatal dopamine receptor supersensitivity by active analogues of L-prolyl-L-leucyl-glycinamide (PLG)RAJAKUMAR, G; NAAS, F; JOHNSON, R. L et al.Peptides (New York, NY. 1980). 1987, Vol 8, Num 5, pp 855-861, issn 0196-9781Article

Neuropeptide Y in the intermediate lobe of the frog pituitary acts as an α-MSH-release inhibiting factorDANGER, J.-M; LEBOULENGER, F; GUY, J et al.Life sciences (1973). 1986, Vol 39, Num 13, pp 1183-1192, issn 0024-3205Article

A COMPARISON BETWEEN A MELANOCYTE-STIMULATING HORMONE INHIBITORY FACTOR (MIF-I) AND SUBSTANCES KNOWN TO ACTIVATE CENTRAL DOPAMINE RECEPTORS = COMPARAISON ENTRE UN FACTEUR INHIBITEUR DE L'HORMONE STIMULANT LES MELANOCYTES (MIF-I) ET LES SUBSTANCES CONNUES POUR ACTIVER LES RECEPTEURS DOPAMINIQUES CENTRAUXCOX B; KASTIN AJ; SCHNIEDEN H et al.1976; EUROP. J. PHARMACOL.; NETHERL.; DA. 1976; VOL. 36; NO 1; PP. 141-147; BIBL. 17 REF.Article

MIF-1 potentiates the action of tricyclic antidepressants in an animal model of depressionKOSTOWSKI, W; DANYSZ, W; DYR, W et al.Peptides (New York, NY. 1980). 1991, Vol 12, Num 5, pp 915-918, issn 0196-9781Article

MIF-1 can accelerate neuromotor, EEG and behavioral development in miceD'AMORE, A; PIERETTI, S; PALAZZESI, S et al.Peptides (New York, NY. 1980). 1990, Vol 11, Num 3, pp 527-532, issn 0196-9781Article

Assessment of TRH as a potential MSH release stimulating factor in Xenopus laevisLIDY VERBURG-VAN KEMENADE, B. M; JENKS, B. G; VISSER, T. J et al.Peptides (New York, NY. 1980). 1987, Vol 8, Num 1, pp 69-76, issn 0196-9781Article

Pharmacological activities of the MIF-1 analogues Pro-Leu-Gly, Tyr-Pro-Leu-Gly and pareptideMYCROFT, F. J; BHARGAVA, H. N; WEI, E. T et al.Peptides (New York, NY. 1980). 1987, Vol 8, Num 6, pp 1051-1055, issn 0196-9781Article

MIF-1 (Pro-Leu-Gly-NH₂) decreases activity Siamese fighting fish (Betta splendens)BROWN, M. M; SARDENGA, P. B; OLSON, G. A et al.Pharmacology, biochemistry and behavior. 1984, Vol 20, Num 4, pp 629-630, issn 0091-3057Article

DEGRADATION OF PROLYLLENCYLGLYCIANAMIDE (MIF) BY MOUSE BRAINNEIDLE A; YESSAIAN N; LAJTHA A et al.1980; NEUROCHEM. RES.; USA; DA. 1980; VOL. 5; NO 9; PP. 1011-1023; BIBL. 22 REF.Article